Connor Clark & Lunn Investment Management Ltd. Purchases 33,063 Shares of Maximus, Inc. (NYSE:MMS)

Connor Clark & Lunn Investment Management Ltd. boosted its position in Maximus, Inc. (NYSE:MMS) by 221.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 47,963 shares of the health services provider’s stock after purchasing an additional 33,063 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Maximus were worth $4,468,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in MMS. Inspire Advisors LLC boosted its stake in Maximus by 1.4% during the second quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock worth $751,000 after acquiring an additional 121 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Maximus by 4.5% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock worth $272,000 after buying an additional 136 shares during the last quarter. WR Wealth Planners LLC increased its position in Maximus by 4.6% during the 2nd quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider’s stock valued at $388,000 after buying an additional 198 shares in the last quarter. CANADA LIFE ASSURANCE Co raised its stake in Maximus by 0.4% during the first quarter. CANADA LIFE ASSURANCE Co now owns 52,681 shares of the health services provider’s stock valued at $4,419,000 after buying an additional 236 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after acquiring an additional 238 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insiders Place Their Bets

In related news, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares of the company’s stock, valued at $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.40% of the company’s stock.

Maximus Price Performance

Shares of NYSE:MMS opened at $73.09 on Friday. The business has a fifty day moving average price of $88.09 and a 200-day moving average price of $87.99. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.59. The company has a market capitalization of $4.40 billion, a PE ratio of 14.62 and a beta of 0.77. Maximus, Inc. has a 1-year low of $71.90 and a 1-year high of $93.97.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.64%. Maximus’s dividend payout ratio is currently 24.00%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.